1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
In this episode we evaluate the IMpassion130 tria…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
October 23, 20181h 2mExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations.
IMpassion130: doi.org/10.1056/NEJMoa1809615
Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters
Topics
medicineoncologyhealthpolicy